Search

everythinglearnresearchcommunity

for

Search:↓

The skin and thymus develop similarly to protect and support immunity.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Mice with a Gsdma3 gene mutation have thicker skin and longer hair follicle openings due to increased β-catenin levels.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Skin health and diseases are closely linked to metabolic processes.

Iron deficiency might contribute to hair loss in women.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.